The FDA has approved an application to initiate a pilot study with Alpha DaRT for patients with recurrent glioblastoma, a ...

Alpha Tau Medical Ltd. (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, ...

Despite decades of research to develop effective treatments, the median survival for glioblastoma—the most common malignant ...

Congress’ move to chop cancer research funding comes at a time where Secretary of Health and Human Services Robert F. Kennedy ...

Spanios is pleased to announce strategic partnership with GlioGuard aimed at propelling discovery and validation of ...

Meghan McCain said Tuesday she’s “absolutely heartbroken” to learn that the recently passed government spending bill wipes ...

Medical announced that the FDA has approved an Investigational Device Exemption, IDE, application to initiate a pilot study ...

An Instagram reel claims that Nicotine cures glioblastoma tumors in less than 72 hours. The claim by the user is ...

A 59-year-old businessman who repeatedly forgot turns of the road while drinking and misplaced things in his office was diagnosed with stage 3 glioblastoma brain tumour. According to Paul Fletcher, ...

The phase 2 GIANT trial will evaluate Opdivo with or without relatlimab in IDH-wildtype newly diagnosed glioblastoma.

All proceeds from Tuesday's benefit dinner will go to Butterfield and his family to help with at-home nursing aides, hospice ...

A DAD who missed turns while driving through his neighbourhood and misplaced his briefcase was given 14 months to live. Paul ...